Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
NN Inc
NNBR
$301M
| $569K | ﹤0.01% |
108,200
-185,256
| -63% | -$1.11M |
|
3102
HF Foods Group
HFFG
$95.9M
| $568K | ﹤0.01% |
93,756
| – | – |
|
3103
iRadimed
IRMD
$1.14B
| $567K | ﹤0.01% |
16,863
| – | – |
|
3104
Puma Biotechnology
PBYI
$453M
| $566K | ﹤0.01% |
80,652
-199,023
| -71% | -$1.49M |
|
|
PRTK
3105
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $566K | ﹤0.01% |
116,342
-186,328
| -62% | -$1.03M |
|
3106
iBio
IBIO
$73M
| $565K | ﹤0.01% |
1,064
| – | – |
|
3107
Sony
SONY
$138B
| $565K | ﹤0.01% |
+25,545
| New | +$535K |
|
|
USX
3108
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $565K | ﹤0.01% |
65,380
| – | – |
|
3109
The ONE Group
STKS
$56.5M
| $564K | ﹤0.01% |
52,702
+3,081
| +6% | +$31.8K |
|
3110
Tiptree Inc
TIPT
$671M
| $559K | ﹤0.01% |
55,701
| – | – |
|
|
ZYXI
3111
DELISTED
Zynex
ZYXI
| $559K | ﹤0.01% |
53,965
+2,147
| +4% | +$27.6K |
|
3112
Korro Bio
KRRO
$196M
| $558K | ﹤0.01% |
1,580
-2,456
| -61% | -$967K |
|
3113
First Bank
FRBA
$464M
| $557K | ﹤0.01% |
39,524
| – | – |
|
3114
Ceco Environmental
CECO
$4.32B
| $555K | ﹤0.01% |
78,744
-97
| -0.1% | -$689 |
|
3115
Park-Ohio Holdings
PKOH
$691M
| $553K | ﹤0.01% |
21,649
-37,129
| -63% | -$1.01M |
|
|
ITI
3116
DELISTED
Iteris, Inc.
ITI
| $547K | ﹤0.01% |
103,476
| – | – |
|
|
ESTE
3117
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $546K | ﹤0.01% |
59,341
| – | – |
|
3118
EyePoint Inc
EYPT
$1.13B
| $545K | ﹤0.01% |
52,273
| – | – |
|
|
AGS
3119
DELISTED
PlayAGS
AGS
| $542K | ﹤0.01% |
68,707
-221,508
| -76% | -$1.76M |
|
|
TRVN
3120
DELISTED
Trevena, Inc.
TRVN
| $542K | ﹤0.01% |
705
+66
| +10% | +$56K |
|
|
FTSI
3121
DELISTED
FTS International, Inc. Common Stock
FTSI
| $540K | ﹤0.01% |
21,944
| – | – |
|
3122
AquaBounty Technologies
AQB
$7.67M
| $539K | ﹤0.01% |
6,613
| – | – |
|
3123
Kinetik
KNTK
$4.11B
| $539K | ﹤0.01% |
15,616
| – | – |
|
3124
Immuneering
IMRX
$311M
| $538K | ﹤0.01% |
+20,236
| New | +$544K |
|
|
MCBC
3125
DELISTED
Macatawa Bank Corp
MCBC
| $538K | ﹤0.01% |
66,891
| – | – |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.